PDE5A and chronic obstructive pulmonary disease: Despite the fact that PDE5 inhibitors have already been used in clinical trials in COPD patients with and without PH [17–25], this study provides the thus far missing data of long term treatment with PDE inhibitors and assesses detailed effects on alveolar and vascular structure which was not possible in the respective human studies.